ception (Harter total scale: p ! 0.01), and bodily attitude (Baardman: p ! 0.05) was signifi cantly less positive than for their normal Dutch peers, we found no evidence of depression. TS women rated their family functioning higher than their Dutch peers (p ! 0.0001), and had a slightly different coping pattern. These results show that even after reaching a height in most cases within the normal range and puberty induction at a pubertal age, some women with TS still experience psychosocial problems. It is likely, however, that GH and estrogen treatment improved psychosocial functioning. Long-term follow-up of these GH-treated patients will allow an evaluation of their life achievements.
egy on psychosocial functioning. Untreated girls with TS have been described as being more immature, having a lower self-esteem, poor concentration, and being hyperactive [6, 7] .
In the present study, we evaluated psychosocial functioning in a group of 50 women with TS, after reaching fi nal height in two multicenter GH trials.
Methods

GH Group
All women who had participated in two GH trials (see below), had discontinued GH treatment for more than 6 months, and were able to fi ll in the questionnaires, were asked to participate in the psychosocial evaluation. Fifty women agreed to participate (response rate 50/69: 72%). Nineteen girls did not participate either because of practical reasons or because of losing interest in participating in a study.
Both GH trials evaluated the effect of GH on long-term growth and ultimately on fi nal height (FH). At time of the psychosocial evaluation, all participants were prescribed hormone replacement therapy in an adult dose.
Dose-Response GH Trial
Sixty-eight previously untreated Dutch girls with TS, aged between 2 and 11 years, were enrolled in an open randomized multicenter GH dose-response study (DRS) . Biosynthetic GH (r-hGH Norditropin ® , Novo Nordisk A/S, Denmark) was given subcutaneously once daily in a dosage of 4, 6, or 8 IU GH/m 2 body surface area/day ( ϳ 0.045-0.09 mg/kg/day). Puberty was induced at age 12 years (study design as described previously [5] ). Six girls dropped out of the study and were lost to follow-up. Six girls had not discontinued GH treatment for more than 6 months and 4 girls were unable to fi ll in the questionnaires due to mental retardation, leaving 52 girls able to participate in the psychosocial evaluation.
Frequency-Response GH Trial
Nineteen previously untreated Dutch girls aged 11 years or older, with TS, were enrolled in an open randomized multicenter GH frequency-response study (FRS) . Biosynthetic GH was given subcutaneously once or twice daily in a total dosage of 6 IU GH/m 2 / day. Puberty was induced at start of trial (study design as described previously [1] ). Two girls were unable to fi ll in the questionnaires due to mental retardation, leaving 17 girls able to participate in the psychosocial evaluation.
The GH trials and the psychological evaluation were approved by the Ethics Committees of the participating centers in the Netherlands. Written informed consent was obtained from the parents or custodians of each child.
Normal Population Sample
From a randomly selected population sample from three municipalities in the Netherlands (n = 600, response rate 56%), only the females were selected for comparison (n = 359) [8] .
Psychosocial Evaluation
In the GH group a psychosocial evaluation was performed after GH treatment had been discontinued for at least 6 months and (near) FH had been reached. Questionnaires for the GH trial groups and the population sample were sent by post.
General Information. Data on occupational and educational levels were provided by both parents and adolescents. Parental occupational level (SES) ranged from 1 (lower occupation) to 3 (higher occupation). When both parents were employed the highest of both SES levels was used. For unemployment the lowest SES was used [9] .
Behavioral Problems (YSR/YASR) . Behavioral problems were measured by 3-point scale standardized questionnaires from Achenbach, translated and validated in the Dutch language [8, 10, 11] . For girls aged between 12 and 18 years, the 119-item Youth Self-Report (YSR; fi lled in by child) [12, 13] was used. For girls aged 18 years and older, the 127-item Young Adult Self-Report (YASR; fi lled in by adolescent) was used [14] . As both questionnaires were constructed in a similar way, results from three scales could be combined for analysis (Internalizing, Externalizing, and Total Problem score). To allow combination of test scales (YSR/ YASR), z-scores were constructed using the Population sample data as reference [8] . A higher test z-score indicated more problem behavior.
Self-Perception (HSPP). The inventory, called in Dutch 'Hoe ben ik' and in English 'Harter Self Perception Profi le', was designed by Harter to describe sense of self-worth and capability in several areas, using 4-point scales. [15, 16] . In the evaluation the 45-item adolescent-version (HSPP-a) was used. Ten scales (Scholastic competence, Social acceptance, Athletic competence, Physical appearance, Behavioral conduct, Global self-worth, Romantic appeal, Close friendship, Job competence, and Total HSP score) were used for analysis (median ␣ = 0.76). A higher test score indicated a more favorable self-perception.
Child Depression Inventory (CDI). The American Child Depression Inventory was designed to measure depressive thoughts and feelings in a child population and was designed by Kovacs [17] . Factor analysis of the Dutch version of the 27-item (3-point scales) 'Gevoelens en Gedachten vragenlijst' produced one scale, the 'Total depression scale score' ( ␣ = 0.86) [8] . A higher score indicated more depressive thoughts and feelings.
Body Attitude Scale (BAS). The Dutch questionnaire 'Lichaamsbelevings vragenlijst' is a 45-item questionnaire and uses a 5-point Likert scale to assess bodily attitude. It has been constructed and validated by Baardman et al. [18] . In an adolescent population, three scales could be distinguished by factor analysis: 'Appraisal' ( ␣ = 0.94; e.g. 'Are you satisfi ed with the way your body looks?'), 'Attribution' ( ␣ = 0.88; e.g. 'Do you think people avoid you because of your appearance?'), and 'Physical contact' ( ␣ = 0.77; e.g. 'In general, how much do you like touching people?') [8] . High test scores indicated positive bodily attitudes.
Family Assessment Device (FAD). This shorter 12-item version of the General Functioning Subscale of the McMaster Family Assessment Device measured overall family functioning, using a 4-point scale. Reliability and validity were tested in the original language [19] and in Dutch [20] . A higher test score indicated more positive family functioning.
Coping (UCL) . The 'Utrecht Coping list' [21] was designed and validated in Dutch [22, 23] . The 47-item 4-point scale list was made to measure 7 ways of coping with stressful events: Active approach 
Statistical Analysis
All data were expressed as mean (SEM) unless otherwise specifi ed. Differences in SES between the Population sample and the GH group were analyzed by logistic regression analyses. To analyze differences in results between the GH group and the Population sample regression analyses were used, corrected for age, GH trial (1 dummy variable: FRS = 1) and GH dosage (2 dummy variables). SES (2 dummy variables) was only corrected for when signifi cant. The effect FH, corrected FH, and the increase in height from start of GH treatment were estimated by the addition of FH SD score, corrected FH SD score and height SD score at start to the regression models, with correction for age, GH trial, and GH dosage. Results from the regression analyses were shown as unstandardized coeffi cients (B) with their two-tailed p values. All calculations were done by SPSS 9.0. A p value of 0.05 was considered signifi cant for comparison between the GH group and the normal sample. A p value ! 0.01 was considered signifi cant for within GH group comparison because of multiple testing.
Results
Clinical data of the GH trials are shown in table 1 for all women who participated in the psychosocial evaluation. We found no signifi cant differences in clinical data between TS women participating in this psychosocial study and TS women who did not participate. Psychosocial data for the DRS and FRS were analyzed together (GH group). Correction for GH trial (FRS or DRS) and GH dosage did not have a signifi cant infl uence on results.
Social Economic Status (SES)
In the GH group, 35% had a low SES level, 20% an intermediate level, and 46% a high level. The differences in SES between the GH group and the Population sample (33/34/33%, respectively) were not signifi cant. Correction for SES did not signifi cantly change any of the following results.
Behavior (YSR/YASR)
Internalizing, Externalizing, and Total problem behavior SD scores were comparable to the Population sample mean ( table 2 ) .
Self-Perception (HSPP)
Total HSP scores ( table 3 ) were signifi cantly lower than the Population sample scores (B = -0.30, p ! 0.01), while GH dosage had no signifi cant effect. To explain this result, we examined the remaining scale scores, which are the components of the Total HSP scores. Social acceptance, Athletic competence, and Romantic appeal scores were also signifi cantly lower than the Population sample scores (B = -0.63, p ! 0.001, B = -0.55, p ! 0.01, B = -0.40, p ! 0.05, respectively). The remaining scale scores were not signifi cantly different to the Population sample scores. 
Child Depression Inventory (CDI)
Total depression scale scores were not signifi cantly different to the Population sample scores ( table 4 ).
Body Attitude Scale (BAS)
Attribution and Physical contact were scored slightly but signifi cantly lower than the Population sample (B = -0.26, p ! 0.05, B = -0.41, p ! 0.05, respectively; table 4 ). Appraisal scores, however, were not signifi cantly different to the Population sample scores.
Family Assessment Device (FAD)
The Total FAD scale scores were signifi cantly higher than the Population sample scores (B = 0.77, p ! 0.0001; table 4 ).
Coping (UCL)
Compared to the Population sample scores, only the scale Reassuring thoughts was signifi cantly higher in the dose-response group (B = 0.32, p ! 0.05). Scores for the scales Active approach, Expression of emotion, Palliative reaction, Passive reactional pattern, Seeking social support, and Avoiding/Anticipating were not signifi cantly different to the Population sample ( table 5 ) .
Correlations between Tests
To assess possible relations between the results, which were signifi cantly different from the Population sample, partial correlations were done, corrected for GH dosage. The Total HSP score was signifi cantly correlated to the Total FAD score (r = 0.38, p = 0.01), the BAS Attribution score (r = 0.61, p ! 0.001) and the BAS Physical contact score (r = 0.57, p ! 0.001). No correlation was found be- Regression analyses, corrected for age, GH trial, and GH dosage: No signifi cant differences (GH group vs. Population sample). Regression analyses, corrected for age, GH trial, and GH dosage: * p < 0.05, ** p < 0.01, *** p < 0.001; two-tailed (GH group vs. Population sample). Regression analyses, corrected for age, GH trial, and GH dosage: * p < 0.05 *** p < 0.001; two-tailed (GH group vs. Population sample). tween the Total HSP score and the UCL Reassuring thoughts score. Total FAD score was signifi cantly correlated with the BAS Physical contact score (r = 0.46, p = 0.001), while no correlation was found between Total FAD score and the BAS Attribution score, or the UCL Reassuring thoughts score.
Effect of Final Height
FH SD score or corrected FH SD score, with or without correction for height SD score at start, showed no signifi cant effect on Behavioral SD scores, Self-perception (Total HSP) scores, Depression scores, Bodily Attitude scores or Family functioning scale (FAD) scores. Correction for height SD score at start did not affect results.
Discussion
Our study presents psychosocial functioning results of women with TS after reaching FH in two GH trials. We measured psychosocial functioning by standardized questionnaires on behavioral problems, self-perception, depression, bodily attitude, family functioning, and coping. We show that after long-term GH treatment, behavior of the TS women was comparable to normal Dutch peers. In contrast, we show their self-perception, and their attitude towards their bodies was slightly less positive than for their normal Dutch peers. We found no evidence of increased symptoms of depression, TS women rated their family functioning higher, and had a slightly different coping pattern compared to their Dutch peers.
We show that self-rated problem behavior scores did not signifi cantly differ from normal Dutch peers. Although we did not evaluate psychosocial functioning before start of GH treatment in our TS group, many studies have found that untreated adolescent girls with TS have more problem behavior than normal girls [24, 25] . Our results therefore suggest an improvement in problem behavior, after reaching a FH within the normal range for most and puberty induction at a pubertal age. According to Ross et al. [7] improvement in (parent-reported) behavioral problems could be explained by the estrogen substitution alone. In other studies, similar improvement in behavior can be found after several years of GH treatment [26, 27] .
Regarding self-perception, our results show that after reaching a FH, in most cases, in the normal range while puberty was induced at a relatively normal age (12 years in the majority), self-perception total score was significantly lower than in normal Dutch girls. We found that the TS women feel they are less socially accepted, are less athletic, and have a lower romantic appeal than normal girls. Similar fi nding have been reported in untreated girls and women with TS [28, 29] . Several studies, however, have shown that treatment with estrogens and/or GH treatment improved self-perception [7, 25, 26] . Whether, in our study, scores for self-perception were even lower before start of GH treatment, we cannot say. But, even if scores had improved during the GH trials, they did not normalize. A possible reason why self-perception remained lower than normal could be the insecurity brought about by having typical physical TS features. Another reason might be the incidental observation of both parents and clinicians that some girls seem to lack social graces. To substantiate this observation, a recent study showed TS women have an impairment in recognizing emotions on someone's face compared with normal women, possibly indicating anomalies in amygdala function [30] . Another reason why our TS group feels less athletic might be because they actually have a restriction in movement. Nijhuis-van der Sanden et al. [31] found that, although TS girls move with the same accuracy as their normal peers, they move with a signifi cantly lower speed and conclude that TS girls have a problem in execution of movement. Due to the age of the participants (mean age of 18 years) the role of infertility was not investigated. Based on our professional experience, infertility has a larger role on self-perception later in life.
Several studies have found evidence of depression in TS women who were untreated or only treated with estrogens [32, 33] . In our group of TS women, after longterm GH treatment and estrogen substitution at a pubertal age, the results of the questionnaire show no significant signs of depression. A previous study on adolescent girls with TS treated with GH (100%) and estrogen (61%) described severe depressive symptoms in 20% [34] of the girls. The factor related to these symptoms was teasing by peers about their physical appearance. Rickert et al. [34] , however, did not show any data on height gain or pubertal development during GH and estrogen treatment. Therefore, the discrepancy in results might be explained by differences in height gain or pubertal development. Since we found no evidence of depression, this might indicate the girls suffered less from teasing as a result of adequate GH and estrogen treatment.
Furthermore, our results show that after GH treatment and puberty induction TS women appraise their bodies similarly to their peers. Other studies have shown that TS girls and women when untreated score their physical appearance signifi cantly lower than their peers [28, 35] . Interestingly, the TS women have a small but signifi cant tendency to attribute problems to their appearance and avoid physical contact. Although our group was adequately treated with GH and estrogen, we did not treat the typical physical TS features, other than short stature and absent pubertal development. It is therefore not surprising that they still feel insecure about their appearance.
Previous studies found girls with TS are often overprotected by their parents [26] . Overprotection, however, is also seen in other patient groups with short stature [36] . One of the reasons for parents to overprotect is lack of peer relations of their children. On the other hand, children with poor peer relations rely more on family functioning [37] . Several studies describe an increase in family functioning, parallel to an increase in self-concept and a decrease in behavioral problems during GH treatment [25, 26] . In our study, after reaching a FH within the normal range in most cases and puberty induction at a relatively normal age, we found that TS women have a better family functioning than peers. This might indicate that these TS women still lack peer relations and take refuge in their family as a way of coping with problems [25] . Another explanation might be that as a result of past medical and psychosocial problems these TS women and their families have faced, their families actually function better than peer families. Rovet et al. [26] , in their controlled GH trial, found an increase in family functioning and explained this as a greater involvement of the parents due to the GH treatment.
Commonly, girls and women with TS are described as withdrawing from social interaction as a way of coping with problems [25, 38] . Interestingly, we show that women with TS, after long-term GH and estrogen treatment, have only a slightly different coping strategy than their peers. They used more Reassuring thoughts to cope with problems, while they used strategies such as Avoiding problems but also Active approach and Expression of emotions as often as their peers. These results seem to indicate that, in general, TS women, after adequate GH and estrogen treatment, have a 'normal' coping strategy.
When we looked at the relation between our results, we found that TS women, who have a good self-perception, also have a good family functioning, attribute problems less to their appearance and enjoy physical contact. These results strengthen the common suggestion that these TS women rely on family functioning more than other women [37] , which for them leads to a more favorable self-perception and bodily attitude. Previous studies have described that the TS women rely on their families more than other women as a way to avoid problematic situations [25, 37] . In the GH group, we show that these women avoid problems similarly to their peers.
As mentioned before, several studies show more behavioral problems in untreated TS girls and a decrease in problems during GH treatment [25, 26] . Similarly, for self-perception, an improvement has been found during GH and estrogen treatment [25, 26] . Although it is therefore likely that in our study, GH and estrogen treatment has had a positive effect on psychosocial development, we did not fi nd signifi cant relationships between test scores and (corrected) FH or a GH dosage effect. This might also indicate that GH treatment did not infl uence psychosocial functioning. Another explanation for this might be that the GH treatment regimen in the trials, regardless of the dosage, achieved its optimal effect on psychosocial functioning. Similarly, in short children born small for gestational age, while longitudinal results show a signifi cant increase in psychosocial functioning during GH treatment, results did not differ between GH dosage groups [39] . In the present study, however, we are unable to show the extent of the effect of GH treatment, as we have no psychosocial data of start of the GH trials.
In conclusion, after long-term GH treatment, behavior of the TS women was comparable to normal Dutch peers. Although their perception of themselves and their attitude towards their own bodies was slightly less positive than for their normal Dutch peers, we found no evidence of depression. In addition, TS women rated their family functioning higher, and had a coping pattern very similar to their Dutch peers. TS women with a more positive selfperception also had a better attitude towards their bodies and had a better functioning family. These results show that even after reaching a height within the normal range and puberty induction at a pubertal age, some women with TS still experience psychosocial problems. It is, however, likely that GH and estrogen treatment improved psychosocial functioning. Long-term follow-up of these GH-treated patients will allow an evaluation of their life achievements.
